phase i study of donor-derived γδ t cells as relapse prophylaxis post haplo/cy
Published 1 year ago • 62 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:52
results of phase i study of mcl-1 inhibition with azd5991 in r/r hematologic malignancies
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
1:52
phase i dose-escalation study of the bet inhibitor incb057643 in r/r myelofibrosis
-
26:21
erythrocytes, hemoglobin & the iron cycle
-
5:30
glofitamab in r/r dlbcl: updated safety and efficacy data
-
1:44
flowsaver blood return system
-
3:46
overview of a phase i study of ono/gs-4059 in relapsed and refractory mature b-cell malignancies
-
2:43
insights into phase i/ii study assessing fixed-duration glofitamab treatment for r/r lbcl
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:48
an ongoing phase i/ii dose-finding study of zn-d5 for r/r al amyloidosis
-
1:07
highlights from math by iach: relapse & gvhd prophylaxis
-
1:53
the future of multiple myeloma treatment
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
1:02
maintenance therapy following treatment for amyloidosis